2,556 results match your criteria: "University-Hospital Freiburg[Affiliation]"
Cancers (Basel)
April 2023
Department of Diagnostic and Interventional Neuroradiology, University Hospital Munich (LMU), Marchioninistrasse 15, 81377 Munich, Germany.
Background: The aim of this study was to develop and validate radiogenomic models to predict the MDM2 gene amplification status and differentiate between ALTs and lipomas on preoperative MR images.
Methods: MR images were obtained in 257 patients diagnosed with ALTs ( = 65) or lipomas ( = 192) using histology and the MDM2 gene analysis as a reference standard. The protocols included T2-, T1-, and fat-suppressed contrast-enhanced T1-weighted sequences.
Eur J Cardiothorac Surg
April 2023
Department of Cardiovascular Surgery, University Hospital Freiburg, Heart Centre Freiburg, Freiburg, Germany.
Insights Imaging
April 2023
Instituto Politécnico de Coimbra, ESTESC - Coimbra Health School, Medical Imaging and Radiotherapy, Rua 5 de Outubro, S. Martinho Do Bispo, 3046-854, Coimbra, Portugal.
Purpose: To analyse the existing radiation protection (RP) education and training (E&T) capabilities in the European Union and identify associated needs, problems and challenges.
Method: An online survey was disseminated via the EURAMED Rocc-n-Roll consortium network and prominent medical societies in the field of radiological research. The survey sections analyse the RP E&T during undergraduate, residency/internship and continuous professional development; RP E&T problems and legal implementation.
Neurosurg Focus
April 2023
1Department of Neurosurgery, Cantonal Hospital St. Gallen.
Objective: Acute hydrocephalus is a frequent complication after aneurysmal subarachnoid hemorrhage (aSAH). Among patients needing CSF diversion, some cannot be weaned. Little is known about the comparative neurological, neuropsychological, and health-related quality-of-life (HRQOL) outcomes in patients with successful and unsuccessful CSF weaning.
View Article and Find Full Text PDFTrials
March 2023
Hannover Medical School, Department of Gastroenterology, Hepatology and Endocrinology, Carl-Neuberg Strasse 1, 30625, Hannover, Germany.
Background: Progress of cholangitis to cholangiosepsis is a frequent observation in patients with secondary sclerosing cholangitis in critically ill patients (SSC-CIP). Adequate biliary drainage may reduce episodes of cholangiosepsis and therefore stabilize liver function and improve survival. The primary objective of the BISCIT study is to demonstrate that scheduled biliary interventions will reduce incidence of cholangiosepsis, liver transplantation, or death in patients with SSC-CIP.
View Article and Find Full Text PDFKnee
June 2023
Department of Orthopedic and Trauma Surgery, University Hospital Freiburg, Germany.
Background: Occupational reintegration after anterior cruciate ligament (ACL) rupture is an important clinical issue including economic and health-related perspectives. This study aims to develop and validate a clinical prediction model of return to work in patients with ACL reconstruction surgery considering evidence-based clinical, anthropometric and occupational factors.
Methods: Data of 562 patients with an ACL rupture receiving an arthroscopic ACL reconstruction were used for analysis.
medRxiv
March 2023
Institute of Human Genetics, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, 81675, Germany.
Background: Congenital anomalies of the kidney and urinary tract (CAKUT) are the predominant cause for chronic kidney disease below 30 years of age. Many monogenic forms have been discovered mainly due to comprehensive genetic testing like exome sequencing (ES). However, disease-causing variants in known disease-associated genes still only explain a proportion of cases.
View Article and Find Full Text PDFThorac Cardiovasc Surg
June 2023
Department of Cardiovascular Surgery, Heart Centre Freiburg, University Hospital Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Eur J Paediatr Neurol
May 2023
Department of Neurology Erasmus MC- Sophia Children's Hospital, University Medical Center Rotterdam, the Netherlands; Department of Immunology Erasmus MC- Sophia Children's Hospital, University Medical Center Rotterdam, the Netherlands. Electronic address:
Background: Guillain-Barré syndrome (GBS) has a highly variable clinical course and outcome as indicated by the risk of developing respiratory failure and residual inability to walk. Prognostic models as Erasmus GBS Respiratory Insufficiency Score (EGRIS) developed in adult patients are inaccurate in children. Our aim was to determine the prognostic factors of respiratory failure and inability to walk in children with GBS and to develop a new clinical prognostic model for individual patients (EGRIS-Kids).
View Article and Find Full Text PDFNeurology
May 2023
From the Department of Neurology (J. Peltola, S.J.), Tampere University and Tampere University Hospital, Finland; Academic Center for Epileptology Kempenhaeghe/MUMC+ (A.J.C., L.A., R.P.W.R., L.W.), Maastricht, the Netherlands; Department of Neurosciences and Mental Health (J. Pimentel), Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Portugal; Department of Stereotactic and Functional Neurosurgery (V.A.C.), Universitätsklinikum Freiburg, Germany; Neurology Department (A.G.-N.), Epilepsy Program, Hospital Ruber Internacional, Madrid, Spain; Department of Neurosurgery (A.G.F., A.R.C.), Hospital Santa Maria Centro Hospitalar Lisboa Norte, Portugal; Department of Neurosurgery (K.L.), Tampere University Hospital and Tampere University, Finland; Département des Neurosciences Cliniques (P.R.), centre hospitalier universitaire vaudois (CHUV), Lausanne, Switzerland; MRC/CSO Social and Public Health Sciences Unit & Robertson Centre for Biostatistics (R.S.T.), Institute of Health and Well Being, University of Glasgow; College of Medicine and Health (R.S.T.), University of Exeter, United Kingdom; Departments of Neurosurgery (L.A., Y.T.), Maastricht University Medical Center, the Netherlands; Stichting Epilepsie Instellingen Nederland (SEIN) (J.A.), Zwolle; Neurophysiology Monitoring Unit (C.B.), Department of Neurosciences and Mental Health, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte; Faculdade de Medicina (C.B., A.R.P.), Universidade de Lisboa, Portugal; Department of Neurology (M.B.), Jagiellonian University Medical College, Faculty of Medicine, Krakow, Poland; Western University (J.G.B., A.P.), London, Ontario, Canada; Neurosurgery Department (C.C., P.L., R.V.), Centro Hospitalar Universitário de São João, Porto, Portugal; Department of Epileptology (C.E.E., A.R.), University Hospital Bonn, Germany; National Institute of Clinical Neuroscience (L.E.); Országos Idegtudományi Intézet/National Institute of Neurosciences (D.F.), Budapest, Hungary; North Bristol NHS Trust (H.F.), Bristol, United Kingdom; Wojewodzki Szpital Specjalistyczny w Lublinie (J.G.), Poland; Institute for Neuromodulation and Neurotechnology (A.G.), Department of Neurosurgery and Neurotechnology, University of Tübingen, Germany; Department of Neurosurgery (M.I.), Umberto I General University Hospital, Università Politecnica delle Marche, Ancona, Italy; Department of Neurology (J.J.), Medical School, University of Pécs, Hungary; Department of Neurology (E. Kaufmann), Ludwig Maximilians University, Munich, Germany; Medisch Spectrum Twente (MST) (K.H.K.), Enschede, the Netherlands; Department of Neuroscience (E. Kumlien), Uppsala University, Sweden; Klinik für Neurologie (H.L.), Universitätsklinikum Schleswig-Holstein, Campus Kiel, Christian-Albrechts-Universität zu Kiel, Germany; Neurology and Clinical Neurophysiology Unit (C.L.), Department of Neuroscience, "S. Maria della Misericordia" University Hospital, Udine, Italy; Klinikum der Universität München (S.N.), Großhadern Neurologische Klinik und Poliklinik, Germany; Medizinische Universität Wien (E.P.), Austria; Southmead Hospital (N.K.P.), North Bristol NHS Trust, United Kingdom; Laboratory of EEG/Sleep (A.R.P.), Department of Neurology, Department of Neurosciences and Mental Health, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Portugal; Neurophysiology Unit (R.R.), Neurology Department, Centro Hospitalar Universitário de São João, Porto, Portugal; Department of Neurosurgery (R.A.R.), Viterbo Hospital, Italy; Epilepsy Unit (S.R.), Department of Neurosurgery and Neurotechnology, University of Tübingen, Germany; Department of Neurology (R.P.W.R.), Maastricht University Medical Centre+; School for Mental Health and Neurosciences (R.P.W.R.), Maastricht University, the Netherlands; University Hospital Freiburg (A.S.-B.), Germany; Amsterdam University Medical Center (R.S.), the Netherlands; Department of Neurology (M.S.), Ghent University Hospital, Ghent University, Belgium; Federal Centre of Neurosurgery (Tyumen) (A.S.), I.M. Sechenov First Moscow State Medical University, Moscow, Russia; UZ Leuven (T.T.); Department of Neurology (W.V.P.), UZ Leuven; Laboratory for Epilepsy Research (W.V.P.), KU Leuven; Department of Neurosurgery (D.V.R.), and Department of Neurology (K.V., P.A.J.M.B.), Ghent University Hospital, Ghent University, Belgium; Stichting Epilepsie Instellingen Nederland (SEIN) (J.Z.), Heemstede; Clinical Department (A.A., T.C.B.), Medtronic Internal Trading Sàrl, Tolochenaz, Switzerland; and Medtronic Bakken Research Center (F.G.), Maastricht, the Netherlands.
Background And Objectives: The efficacy of deep brain stimulation of the anterior nucleus of the thalamus (ANT DBS) in patients with drug-resistant epilepsy (DRE) was demonstrated in the double-blind Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy randomized controlled trial. The Medtronic Registry for Epilepsy (MORE) aims to understand the safety and longer-term effectiveness of ANT DBS therapy in routine clinical practice.
Methods: MORE is an observational registry collecting prospective and retrospective clinical data.
Vasa
May 2023
Brandenburg Medical School Theodor Fontane, Campus, Clinic Brandenburg, Berlin, Germany.
Together with colleagues from different disciplines, including cardiologists, interventional radiologists and vascular surgeons, committee members of the of the German Society of Angiology ( []), developed a novel algorithm for the endovascular treatment of peripheral chronic total occlusive lesions (CTOs). Our aim is to improve patient and limb related outcomes, by increasing the success rate of endovascular procedures. This can be achieved by adherence to the proposed crossing algorithm, aiding the standardization of endovascular procedures.
View Article and Find Full Text PDFN Engl J Med
March 2023
University Hospital Freiburg-Bad Krozingen, Bad Krozingen, Germany.
Trials
March 2023
Department of General and Visceral Surgery and Clinical Trial Centre Department of Surgery (ulmCARES), University Hospital Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany.
Background: Oesophageal cancer (EC) is the sixth leading cause of cancer death worldwide. Oesophageal resection is the only curative treatment option for EC which is frequently performed via an abdominal and right thoracic approach (Ivor-Lewis operation). This 2-cavity operation is associated with a high risk of major complications.
View Article and Find Full Text PDFRadiother Oncol
June 2023
Department of Radiotherapy and Radiation Oncology, University Hospital Leipzig, 04103 Leipzig, Germany.
Purpose: To establish and confirm prevalence as well as risk factors of financial toxicity in a large national cohort of cancer patients undergoing radiotherapy in a universal health care system.
Methods: We conducted a prospective cross-sectional study offering a patient-reported questionnaire to all eligible cancer patients treated with radiotherapy in 11 centers in Germany during 60 consecutive days. The four-point subjective financial distress question of the EORTC QLQ-C30 was used as a surrogate for financial toxicity.
Ann Oncol
April 2023
Department of Thoracic Oncology, Airway Research Center North, German Center for Lung Research, Lung Clinic, Grosshansdorf, Germany.
medRxiv
September 2024
Epilepsy Research Centre, University of Melbourne, Austin Health, Heidelberg 3084, Australia.
Identifying genetic risk factors for highly heterogeneous disorders like epilepsy remains challenging. Here, we present the largest whole-exome sequencing study of epilepsy to date, with >54,000 human exomes, comprising 20,979 deeply phenotyped patients from multiple genetic ancestry groups with diverse epilepsy subtypes and 33,444 controls, to investigate rare variants that confer disease risk. These analyses implicate seven individual genes, three gene sets, and four copy number variants at exome-wide significance.
View Article and Find Full Text PDFAnn Rheum Dis
January 2024
Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
Objectives: To develop treat-to-target (T2T) recommendations in giant cell arteritis (GCA) and polymyalgia rheumatica (PMR).
Methods: A systematic literature review was conducted to retrieve data on treatment targets and outcomes in GCA/PMR as well as to identify the evidence for the effectiveness of a T2T-based management approach in these diseases. Based on evidence and expert opinion, the task force (29 participants from 10 countries consisting of physicians, a healthcare professional and a patient) developed recommendations, with consensus obtained through voting.
Haematologica
August 2023
Department of Pediatric Hematology and Oncology, University Children's Hospital Tübingen, Tübingen.
Therapy-resistant viral reactivations contribute significantly to mortality after hematopoietic stem cell transplantation. Adoptive cellular therapy with virus-specific T cells (VST) has shown efficacy in various single-center trials. However, the scalability of this therapy is hampered by laborious production methods.
View Article and Find Full Text PDFJACC Cardiovasc Interv
February 2023
Brandenburg Medical School Theodor Fontane, Campus, Clinic Brandenburg, Brandenburg an der Havel, Berlin, Germany.
A crossing algorithm was developed for the endovascular treatment of peripheral chronic total occlusive lesions (CTOs) to educate, guide, and appropriately influence clinical practice aiming at harmonization and standardization of endovascular procedures. The following steps are proposed: One, duplex sonography and if required computed tomography or magnetic resonance angiography for the selection of the optimal access site. Two, angiographic evaluation of the proximal/distal cap morphology, presence of collaterals at the origin of the proximal cap and at the distal vessel refilling site.
View Article and Find Full Text PDFInvest Radiol
May 2023
From the Empirical Inference Department, Max-Planck Institute for Intelligent Systems.
Objectives: The UK Biobank (UKBB) and German National Cohort (NAKO) are among the largest cohort studies, capturing a wide range of health-related data from the general population, including comprehensive magnetic resonance imaging (MRI) examinations. The purpose of this study was to demonstrate how MRI data from these large-scale studies can be jointly analyzed and to derive comprehensive quantitative image-based phenotypes across the general adult population.
Materials And Methods: Image-derived features of abdominal organs (volumes of liver, spleen, kidneys, and pancreas; volumes of kidney hilum adipose tissue; and fat fractions of liver and pancreas) were extracted from T1-weighted Dixon MRI data of 17,996 participants of UKBB and NAKO based on quality-controlled deep learning generated organ segmentations.
Future Oncol
January 2023
Merck & Co., Inc., 90 E Scott Ave, Rahway, NJ 07065, USA.
Current treatment for patients with metastatic hormone-sensitive prostate cancer (mHSPC) delays disease progression and improves survival, but resistance is inevitable. Additional therapies that prolong survival are needed. Androgen deprivation therapy (ADT) combined with next-generation hormonal agents, such as enzalutamide, is standard-of-care for men with mHSPC.
View Article and Find Full Text PDFEpilepsia Open
June 2023
Department of Pediatric Neurology, Charité - University Medicine Berlin, Berlin, Germany.
Objective: Cannabidiol (CBD) is approved for treatment of Dravet syndrome (DS), Lennox-Gastaut syndrome (LGS), and tuberous sclerosis complex (TSC). Several studies suggest antiseizure effects also beyond these three epilepsy syndromes.
Methods: In a retrospective multicenter study, we analyzed the efficacy and tolerability of CBD in patients with epilepsy at 16 epilepsy centers.
Ann Oncol
April 2023
Department of Thoracic Oncology, Airway Research Center North, German Center for Lung Research, Lung Clinic, Grosshansdorf, Germany.
JACC CardioOncol
December 2022
Cardiovascular Imaging Research Center, Department of Radiology and Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Background: The use of immune checkpoint inhibitors (ICI) is associated with cardiovascular (CV) events, and patients with pre-existing autoimmune disease are at increased CV risk.
Objectives: The aim of this study was to characterize the risk for CV events in patients with pre-existing autoimmune disease post-ICI.
Methods: This was a retrospective study of 6,683 patients treated with ICIs within an academic network.
Econ Hum Biol
April 2023
Epidemiology Department, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany; Hannover Medical School (MHH), Germany; German Center for Infection Research (DZIF), Braunschweig, Germany.
Decisions on public health measures to contain a pandemic are often based on parameters such as expected disease burden and additional mortality due to the pandemic. Both pandemics and non-pharmaceutical interventions to fight pandemics, however, produce economic, social, and medical costs. The costs are, for example, caused by changes in access to healthcare, social distancing, and restrictions on economic activity.
View Article and Find Full Text PDF